| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Shanghai Runda Medical Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.96 |
| 52 Week High | CN¥27.70 |
| 52 Week Low | CN¥11.77 |
| Beta | 0.37 |
| 11 Month Change | 30.81% |
| 3 Month Change | 35.65% |
| 1 Year Change | 13.67% |
| 33 Year Change | 65.99% |
| 5 Year Change | 79.96% |
| Change since IPO | 296.18% |
Recent News & Updates
Recent updates
These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Oct 18
Shanghai Runda Medical Technology (SHSE:603108) Has A Somewhat Strained Balance Sheet
Jun 26Shanghai Runda Medical Technology Co., Ltd.'s (SHSE:603108) Earnings Haven't Escaped The Attention Of Investors
Jun 04Does Shanghai Runda Medical Technology (SHSE:603108) Deserve A Spot On Your Watchlist?
Mar 21Shanghai Runda Medical Technology Co., Ltd. (SHSE:603108) Stock Rockets 31% But Many Are Still Ignoring The Company
Mar 04These 4 Measures Indicate That Shanghai Runda Medical Technology (SHSE:603108) Is Using Debt Extensively
Feb 27Shareholder Returns
| 603108 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 8.5% | -0.5% | 2.7% |
| 1Y | 13.7% | -29.1% | 4.6% |
Return vs Industry: 603108 exceeded the CN Life Sciences industry which returned -34.1% over the past year.
Return vs Market: 603108 exceeded the CN Market which returned 0.1% over the past year.
Price Volatility
| 603108 volatility | |
|---|---|
| 603108 Average Weekly Movement | 7.6% |
| Life Sciences Industry Average Movement | 9.9% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in CN Market | 11.4% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 603108 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603108's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,300 | Hui Liu | www.rundamedical.com |
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technical services; and logistic services.
Shanghai Runda Medical Technology Co., Ltd. Fundamentals Summary
| 603108 fundamental statistics | |
|---|---|
| Market cap | CN¥10.76b |
| Earnings (TTM) | CN¥189.62m |
| Revenue (TTM) | CN¥8.76b |
56.7x
P/E Ratio1.2x
P/S RatioIs 603108 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603108 income statement (TTM) | |
|---|---|
| Revenue | CN¥8.76b |
| Cost of Revenue | CN¥6.44b |
| Gross Profit | CN¥2.32b |
| Other Expenses | CN¥2.13b |
| Earnings | CN¥189.62m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 26.47% |
| Net Profit Margin | 2.16% |
| Debt/Equity Ratio | 122.3% |
How did 603108 perform over the long term?
See historical performance and comparison